Kei Nagai

发表

Selective suppression of oral allergen-induced anaphylaxis by Allergin-1 on basophils in mice.

M. Kubo, H. Karasuyama, A. Shibuya, 2019, International immunology.

Environment and chronic kidney disease in farmers

Kei Nagai, 2021, Renal Replacement Therapy.

Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method

K. Yamagata, Kei Nagai, 2015, Clinical and Experimental Nephrology.

Renal Health Benefits of Rural City Planning in Japan

Kei Nagai, Daniel Koo Yuk Cheong, A. Ueda, 2022, Frontiers in Nephrology.

Renal health benefits of sustainable diets in Japan: a review

N. Itsubo, Kei Nagai, Y. Kawate, 2022, Renal Replacement Therapy.

Plasma Exchange Is Highly Effective for Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single‐Center Case Series

K. Yamagata, J. Usui, T. Kawamura, 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study

K. Iseki, I. Narita, C. Combe, 2021, Clinical and Experimental Nephrology.

Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population

K. Iseki, C. Iseki, K. Yamagata, 2019, PloS one.

Cause-specific mortality in the general population with transient dipstick-proteinuria

K. Iseki, I. Narita, Y. Shibagaki, 2019, PloS one.

Estimating the prevalence of definitive chronic kidney disease in the Japanese general population

K. Iseki, K. Yamagata, K. Asahi, 2021, Clinical and Experimental Nephrology.

Impact of collaboration between general practitioners and nephrologists on renal function: an experience in the Hitachi area

Kei Nagai, A. Ueda, 2022, Clinical and Experimental Nephrology.

Environmental Impact of Care for End-stage Kidney Disease on the Earth and Humans

N. Itsubo, Kei Nagai, 2021, JMA journal.

Obesity Is a Risk Factor for Renal Dysfunction Following Persistent Proteinuria: An Observational Cohort Study

Kei Nagai, M. Nakajima, Shinichi Yoshii, 2022, JMA journal.

Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis

Kei Nagai, 2021, Renal Replacement Therapy.

Levels of Soluble NKG2D Ligands and Cancer History in Patients Starting Hemodialysis

K. Yamagata, J. Usui, Masaki Kobayashi, 2022, Frontiers in Nephrology.

Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients

K. Yamagata, A. Zempo-Miyaki, Kei Nagai, 2014, International journal of nephrology.

Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma

Kei Nagai, H. Tachi, A. Ueda, 2022, Case reports in nephrology.

Tie2 Signaling Enhances Mast Cell Progenitor Adhesion to Vascular Cell Adhesion Molecule-1 (VCAM-1) through α4β1 Integrin

Yukio Nakamura, E. Noguchi, A. Shibuya, 2015, PloS one.

Birth Weight and End‐Stage Diabetic Nephropathy in Later Life: A Japanese Multicenter Study

K. Yamagata, Kei Nagai, Chie Saito, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Expression and Function of Allergin-1 on Human Primary Mast Cells

S. Fujieda, E. Noguchi, K. Yamagata, 2013, PloS one.

Successful Use of Tocilizumab in a Case of Multicentric Castleman's Disease and End‐Stage Renal Disease

K. Yamagata, Kei Nagai, A. Ueda, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis.

S. Holdsworth, A. Kitching, Kei Nagai, 2019, Kidney international.

A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3‐like lesion

H. Kojima, M. Nagata, K. Yamagata, 2011, Pathology international.

A case of anti-GBM nephritis following centipede bites and COVID-19 vaccination

Kei Nagai, A. Ueda, Mamiko Iwase, 2021, CEN Case Reports.

Anti-glomerular Basement Membrane Glomerulonephritis During the First Trimester of Pregnancy

K. Yamagata, J. Usui, H. Hamada, 2020, Internal medicine.

Maintenance treatment using the purine-synthesis inhibitor mizoribine in a patient with relapsing thrombotic thrombocytopenic purpura

K. Yamagata, J. Usui, K. Sakai, 2018, CEN Case Reports.

Literature review of allograft adenovirus nephritis and a case presenting as mass lesions in a transplanted kidney without symptoms of urinary tract infection or acute kidney injury

T. Oda, M. Nagata, K. Yamagata, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration

S. Honda, Yun-Gi Kim, M. Miyasaka, 2014, Nature Communications.

Physical functioning in patients with chronic kidney disease stage G3b‐5 in Japan: The reach‐J CKD cohort study

I. Narita, N. Kashihara, T. Wada, 2021, Nephrology.

Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients

K. Yamagata, J. Usui, H. Yanagi, 2021, Clinical and Experimental Nephrology.

A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study

K. Iseki, I. Narita, C. Combe, 2018, Clinical and Experimental Nephrology.

Peritoneal Dialysis Preserves Residual Renal Function and Reduces Oxidative Stress During the Initial Period of Dialysis Therapy.

K. Yamagata, Kei Nagai, A. Ueda, 2017, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis

Kei Nagai, 2023, Medicina.

Preserved peritoneal function by short-term two-day peritoneal rest in hemodialysis combination therapy patients

K. Yamagata, Kei Nagai, A. Ueda, 2020, Journal of Artificial Organs.

A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy

K. Yamagata, J. Usui, Kei Nagai, 2023, Case reports in nephrology.

Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis

Kei Nagai, 2020, Frontiers in Medicine.

Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan

K. Iseki, I. Narita, Y. Shibagaki, 2019, PloS one.

Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population

K. Iseki, I. Narita, Y. Shibagaki, 2021, Clinical and Experimental Nephrology.

Angiopoietin Balance in Septic Shock Patients Treated by Direct Hemoperfusion With Polymyxin B‐immobilized Fiber

Shogo Fujita, K. Yamagata, J. Usui, 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement

N. Okiyama, K. Yamagata, Y. Kondo, 2020, Internal medicine.

High Estimated Glomerular Filtration Rate and Risk of Cancer Mortality in a Japanese Cohort Study: The Ibaraki Prefectural Health Study

F. Irie, T. Sairenchi, K. Yamagishi, 2022, JMA journal.

Actual rates of electricity consumption in blood purification modalities

Yoshiharu Nakamura, Kei Nagai, 2022, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Sustainability in dialysis therapy: Japanese local and global challenge

N. Itsubo, Kei Nagai, A. Ueda, 2021, Renal Replacement Therapy.

Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease

Yoshiharu Nakamura, Kei Nagai, M. Niisaka, 2020, Journal of rural medicine : JRM.

Recovery from severe metabolic alkalosis with acute kidney injury due to gastric cancer: a case report

Yoshiharu Nakamura, Kei Nagai, Takashi Ono, 2021, Journal of rural medicine : JRM.

Use of darbepoetin alfa for myelodysplastic syndrome coincident with chronic kidney disease

K. Yamagata, Kei Nagai, 2016, CEN Case Reports.

Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up

F. Irie, T. Sairenchi, K. Yamagata, 2016, PloS one.

Two autosomal dominant polycystic kidney (ADPKD) cases with advanced renal dysfunction, effectively treated with tolvaptan

K. Yamagata, J. Usui, T. Kawamura, 2016, CEN Case Reports.